The rationale for new therapies in acute ischaemic strokeDYKER, A. G; LEES, K. R.Journal of clinical pharmacy and therapeutics (Print). 1996, Vol 21, Num 6, pp 377-391, issn 0269-4727Article

Remacemide hydrochloride : A double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic strokeDYKER, A. G; LEES, K. R.Stroke (1970). 1999, Vol 30, Num 9, pp 1796-1801, issn 0039-2499Article

Safety and tolerability of GV150526 (a glycine site antagonist at the N-methyl-D-aspartate receptor) in patients with acute StrokeDYKER, A. G; LEES, K. R.Stroke (1970). 1999, Vol 30, Num 5, pp 986-992, issn 0039-2499Article

Duration of neuroprotective treatment for ischemic strokeDYKER, A. G; LEES, K. R.Stroke (1970). 1998, Vol 29, Num 2, pp 535-542, issn 0039-2499Article

Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic strokeDYKER, A. G; EDWARDS, K. R; FAYAD, P. B et al.Stroke (1970). 1999, Vol 30, Num 10, pp 2038-2042, issn 0039-2499Article

Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up studyWEIR, C. J; MURRAY, G. D; DYKER, A. G et al.BMJ. British medical journal (International ed.). 1997, Vol 314, Num 7090, pp 1303-1306, issn 0959-8146Article

Thrombolytic therapy for acute stroke in the United Kingdom : experience from the safe implementation of thrombolysis in stroke (SITS) registerLEES, K. R; FORD, G. A; WAHLGREN, N. G et al.QJM (Oxford. 1994. Print). 2008, Vol 101, Num 11, pp 863-869, issn 1460-2725, 7 p.Article

Apolipoprotein E genotype, coagulation, and survival following acute strokeWEIR, C. J; MCCARRON, M. O; MUIR, K. W et al.Neurology. 2001, Vol 57, Num 6, pp 1097-1100, issn 0028-3878Article

The apolipoprotein E ∈4 allele and outcome in cerebrovascular diseaseMCCARRON, M. O; MUIR, K. W; WEIR, C. J et al.Stroke (1970). 1998, Vol 29, Num 9, pp 1882-1887, issn 0039-2499Article

Agreement between ambulance paramedic- and physician-recorded neurological signs with Face Arm Speech Test (FAST) in acute stroke patientsNOR, A. Mohd; MCALLISTER, C; LOUW, S. J et al.Stroke (1970). 2004, Vol 35, Num 6, pp 1355-1359, issn 0039-2499, 5 p.Article

Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute strokeHOKE, J. F; DYKER, A. G; BARNABY, R. J et al.European journal of clinical pharmacology. 2000, Vol 55, Num 11-12, pp 867-872, issn 0031-6970Article